Cancer biotherapy: An introductory guide
Editat de Annie Young, Lewis Rowett, David Kerren Limba Engleză Paperback – 4 mai 2006
Preț: 735.09 lei
Preț vechi: 1017.86 lei
-28% Nou
Puncte Express: 1103
Preț estimativ în valută:
140.68€ • 146.13$ • 116.86£
140.68€ • 146.13$ • 116.86£
Carte tipărită la comandă
Livrare economică 22-28 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780198566311
ISBN-10: 019856631X
Pagini: 336
Ilustrații: Numerous tables and line drawings
Dimensiuni: 156 x 233 x 19 mm
Greutate: 0.52 kg
Editura: OUP OXFORD
Colecția OUP Oxford
Locul publicării:Oxford, United Kingdom
ISBN-10: 019856631X
Pagini: 336
Ilustrații: Numerous tables and line drawings
Dimensiuni: 156 x 233 x 19 mm
Greutate: 0.52 kg
Editura: OUP OXFORD
Colecția OUP Oxford
Locul publicării:Oxford, United Kingdom
Recenzii
The editors of this new book...provide a good introductory guide to a whole range of biological interventions. The authors do make the very important point that 'individualised' treatment is going to be the order of the day. All cancer are different, we have to find out how different they are with ever-improving laboratory testing, and we have to tailor treatment to suit each cancer's unique profile and bring them back under control biologically.
This introductory guide is essential reading as the transition from the laboratory phase to clinical practice is made. Opening chapters on the cell biology of caner and the immune system set the scene, before the clinical development of biological therapies is addressed. The reader is then guided through the various methods and types of biological therapy...The potential of genetic information to benefit patients concludes this guide. [It is] edited by a team with perspectives in pharmacology, oncology and nursing, and [has] contributions from experts in the various areas of biotherapy.
This introductory guide is essential reading as the transition from the laboratory phase to clinical practice is made. Opening chapters on the cell biology of caner and the immune system set the scene, before the clinical development of biological therapies is addressed. The reader is then guided through the various methods and types of biological therapy...The potential of genetic information to benefit patients concludes this guide. [It is] edited by a team with perspectives in pharmacology, oncology and nursing, and [has] contributions from experts in the various areas of biotherapy.
Notă biografică
David Kerr is Rhodes Professor of Therapeutics and Clinical Pharmacology at the University of Oxford, and Director of the National Translational Cancer Research Network. He is Editor-in-Chief of OUP's journal Annals of Oncology, and is currently working in Oxford to build a new Institute for Cancer Medicine. He was awarded the CBE in 2002.Lewis Rowett is the Executive Editor of the OUP journal Annals of Oncology, Europe's leading clinical oncology journal. He has worked for the European Society for Medical Oncology since 1998.Annie Young was a biochemist prior to training as a nurse. She was instrumental in starting up a home chemotherapy and gene therapy service in Birmingham, and she is now a Nurse Director covering three counties.